The C-terminal self-binding helical peptide of human estrogen-related receptor γ can be druggably targeted by a novel class of rationally designed peptidic antagonists,Journal of Computational Chemistry

当前位置： X-MOL 学术 › J. Comput. Chem. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The C-terminal self-binding helical peptide of human estrogen-related receptor γ can be druggably targeted by a novel class of rationally designed peptidic antagonists
Journal of Computational Chemistry ( IF 3.4 ) Pub Date : 2024-08-19 , DOI: 10.1002/jcc.27473
Zilong Li ₁ , Yue Peng ₁ , Haiyang Ye ₁ , Yunyi Zhang ₁ , Peng Zhou ₁

Affiliation

Orphan nuclear estrogen-related receptor γ (ERRγ) has been recognized as a potential therapeutic target for cancer, inflammation and metabolic disorder. The ERRγ contains a regulatory AF2 helical tail linked C-terminally to its ligand-binding domain (LBD), which is a self-binding peptide (SBP) and serves as molecular switch to dynamically regulate the receptor alternation between active and inactive states by binding to and unbinding from the AF2-binding site on ERRγ LBD surface, respectively. Traditional ERRγ modulators are all small-molecule chemical ligands that can be classified into agonists and inverse agonists in terms of their action mechanism; the agonists stabilize the AF2 in ABS site with an agonist conformation, while the inverse agonists lock the AF2 out of the site to largely abolish ERRγ transcriptional activity. Here, a class of ERRγ peptidic antagonists was described to compete with native AF2 for the ABS site, thus blocking the active state of AF2 binding to ERRγ LBD domain. Self-inhibitory peptide was derived from the SBP-covering AF2 region and we expected it can rebind potently to the ABS site by reducing its intrinsic disorder and entropy cost upon the rebinding. Hydrocarbon stapling was employed to do so, which employed an all-hydrocarbon bridge across the [i, i + 4]-anchor residue pair in the N-terminal, middle or C-terminal region of the self-inhibitory peptide. As might be expected, it is revealed that the stapled peptides are good binders of ERRγ LBD domain and can effectively compete with the native AF2 helical tail for ERRγ ABS site, which exhibit a basically similar binding mode with AF2 to the site and form diverse noncovalent interactions with the site, thus conferring stability and specificity to the domain–peptide complexes.

中文翻译：

人雌激素相关受体 γ 的 C 端自结合螺旋肽可以被一类新型合理设计的肽拮抗剂靶向成药

孤儿核雌激素相关受体 γ （ERRγ）已被公认为癌症、炎症和代谢紊乱的潜在治疗靶点。ERRγ 包含一个调节性 AF2 螺旋尾部，该末端与其配体结合域（LBD）相连，LBD 是一种自结合肽（SBP），作为分子开关，通过分别结合和解结合 ERRγ LBD 表面的 AF2 结合位点来动态调节受体在活性和非活性状态之间的交替。传统的 ERRγ 调节剂都是小分子化学配体，根据其作用机制可分为激动剂和反向激动剂;激动剂通过激动剂构象稳定 ABS 位点中的 AF2，而反向激动剂将 AF2 锁定在该位点之外，以在很大程度上消除 ERRγ 转录活性。在这里，一类 ERRγ 肽拮抗剂被描述为与天然 AF2 竞争 ABS 位点，从而阻断 AF2 与 ERRγ LBD 结构域结合的活性状态。自抑制肽来源于 SBP 覆盖的 AF2 区域，我们预计它可以通过减少再结合时的内在无序和熵成本来有效地重新结合到 ABS 位点。为此采用了碳氢化合物吻合，它在自抑制肽的 N 端、中间或 C 端区域的 [i， i + 4] 锚残基对上采用了全烃桥。正如预期的那样，揭示了吻合肽是 ERRγ LBD 结构域的良好结合物，可以有效地与天然 AF2 螺旋尾竞争 ERRγ ABS 位点，其表现出与 AF2 与该位点基本相似的结合模式，并与该位点形成多种非共价相互作用，从而赋予结构域-肽复合物稳定性和特异性。

更新日期：2024-08-19

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南